Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CROX - US2270461096 - Common Stock

90.54 USD
-0.07 (-0.08%)
Last: 12/26/2025, 10:05:39 AM
Fundamental Rating

7

Overall CROX gets a fundamental rating of 7 out of 10. We evaluated CROX against 45 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CROX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, CROX could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CROX had positive earnings in the past year.
In the past year CROX had a positive cash flow from operations.
Each year in the past 5 years CROX has been profitable.
CROX had a positive operating cash flow in each of the past 5 years.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

With a decent Return On Assets value of 4.25%, CROX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
CROX has a Return On Equity of 13.39%. This is in the better half of the industry: CROX outperforms 73.33% of its industry peers.
CROX has a Return On Invested Capital of 23.59%. This is amongst the best in the industry. CROX outperforms 91.11% of its industry peers.
CROX had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 11.70%.
The last Return On Invested Capital (23.59%) for CROX is above the 3 year average (22.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.25%
ROE 13.39%
ROIC 23.59%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

The Profit Margin of CROX (4.48%) is better than 66.67% of its industry peers.
CROX's Profit Margin has improved in the last couple of years.
CROX has a Operating Margin of 23.11%. This is amongst the best in the industry. CROX outperforms 95.56% of its industry peers.
In the last couple of years the Operating Margin of CROX has grown nicely.
CROX's Gross Margin of 59.08% is fine compared to the rest of the industry. CROX outperforms 75.56% of its industry peers.
In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 23.11%
PM (TTM) 4.48%
GM 59.08%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

CROX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CROX has less shares outstanding
CROX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CROX has an improved debt to assets ratio.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CROX has an Altman-Z score of 3.81. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CROX (3.81) is better than 71.11% of its industry peers.
CROX has a debt to FCF ratio of 1.84. This is a very positive value and a sign of high solvency as it would only need 1.84 years to pay back of all of its debts.
CROX has a Debt to FCF ratio of 1.84. This is amongst the best in the industry. CROX outperforms 84.44% of its industry peers.
A Debt/Equity ratio of 0.97 indicates that CROX is somewhat dependend on debt financing.
CROX has a worse Debt to Equity ratio (0.97) than 75.56% of its industry peers.
Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.84
Altman-Z 3.81
ROIC/WACC2.03
WACC11.62%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

CROX has a Current Ratio of 1.40. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
CROX has a worse Current ratio (1.40) than 80.00% of its industry peers.
CROX has a Quick Ratio of 1.40. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.83, CROX is doing worse than 66.67% of the companies in the same industry.
CROX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.83
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CROX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.09%.
Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.64% on average per year.
Looking at the last year, CROX shows a small growth in Revenue. The Revenue has grown by 0.01% in the last year.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.23% yearly.
EPS 1Y (TTM)-4.09%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-18.89%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-6.2%

3.2 Future

The Earnings Per Share is expected to grow by 2.84% on average over the next years.
Based on estimates for the next years, CROX will show a small growth in Revenue. The Revenue will grow by 2.29% on average per year.
EPS Next Y-6.35%
EPS Next 2Y-3.7%
EPS Next 3Y-2.2%
EPS Next 5Y2.84%
Revenue Next Year-1.85%
Revenue Next 2Y-1.15%
Revenue Next 3Y-0.38%
Revenue Next 5Y2.29%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

CROX is valuated cheaply with a Price/Earnings ratio of 7.15.
Based on the Price/Earnings ratio, CROX is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.59. CROX is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 7.42, the valuation of CROX can be described as very cheap.
93.33% of the companies in the same industry are more expensive than CROX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.03, CROX is valued rather cheaply.
Industry RankSector Rank
PE 7.15
Fwd PE 7.42
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 86.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CROX is valued cheaper than 91.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.56
EV/EBITDA 5.77
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

CROX has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CROX's earnings are expected to decrease with -2.20% in the coming years.
PEG (NY)N/A
PEG (5Y)0.14
EPS Next 2Y-3.7%
EPS Next 3Y-2.2%

0

5. Dividend

5.1 Amount

CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CROCS INC

NASDAQ:CROX (12/26/2025, 10:05:39 AM)

90.54

-0.07 (-0.08%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners99.37%
Inst Owner Change-8.08%
Ins Owners2.82%
Ins Owner Change1.94%
Market Cap4.70B
Revenue(TTM)4.07B
Net Income(TTM)182.55M
Analysts74.55
Price Target92.99 (2.71%)
Short Float %13.53%
Short Ratio3.97
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.3%
Min EPS beat(2)3.5%
Max EPS beat(2)21.1%
EPS beat(4)4
Avg EPS beat(4)13.09%
Min EPS beat(4)3.5%
Max EPS beat(4)21.1%
EPS beat(8)8
Avg EPS beat(8)14.51%
EPS beat(12)12
Avg EPS beat(12)14.26%
EPS beat(16)16
Avg EPS beat(16)14.77%
Revenue beat(2)1
Avg Revenue beat(2)0.15%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.48%
Revenue beat(4)3
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.48%
Revenue beat(8)4
Avg Revenue beat(8)0.38%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)9
Avg Revenue beat(16)0.56%
PT rev (1m)3.86%
PT rev (3m)-0.12%
EPS NQ rev (1m)0.19%
EPS NQ rev (3m)6.9%
EPS NY rev (1m)2.79%
EPS NY rev (3m)2.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.32%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.57%
Valuation
Industry RankSector Rank
PE 7.15
Fwd PE 7.42
P/S 1.15
P/FCF 6.56
P/OCF 6.03
P/B 3.45
P/tB N/A
EV/EBITDA 5.77
EPS(TTM)12.67
EY13.99%
EPS(NY)12.19
Fwd EY13.47%
FCF(TTM)13.79
FCFY15.24%
OCF(TTM)15.02
OCFY16.59%
SpS78.44
BVpS26.25
TBVpS-7.17
PEG (NY)N/A
PEG (5Y)0.14
Graham Number86.51
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 13.39%
ROCE 26.08%
ROIC 23.59%
ROICexc 24.64%
ROICexgc 49.52%
OM 23.11%
PM (TTM) 4.48%
GM 59.08%
FCFM 17.59%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.84
Debt/EBITDA 1.3
Cap/Depr 83.38%
Cap/Sales 1.56%
Interest Coverage 11.87
Cash Conversion 76.65%
Profit Quality 392.36%
Current Ratio 1.4
Quick Ratio 0.83
Altman-Z 3.81
F-Score6
WACC11.62%
ROIC/WACC2.03
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.09%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-18.89%
EPS Next Y-6.35%
EPS Next 2Y-3.7%
EPS Next 3Y-2.2%
EPS Next 5Y2.84%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-6.2%
Revenue Next Year-1.85%
Revenue Next 2Y-1.15%
Revenue Next 3Y-0.38%
Revenue Next 5Y2.29%
EBIT growth 1Y-11.62%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-7.25%
EBIT Next 3Y-5.07%
EBIT Next 5Y3.43%
FCF growth 1Y-14.34%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y-16.78%
OCF growth 3Y20.5%
OCF growth 5Y61.62%

CROCS INC / CROX FAQ

What is the ChartMill fundamental rating of CROCS INC (CROX) stock?

ChartMill assigns a fundamental rating of 7 / 10 to CROX.


What is the valuation status for CROX stock?

ChartMill assigns a valuation rating of 8 / 10 to CROCS INC (CROX). This can be considered as Undervalued.


What is the profitability of CROX stock?

CROCS INC (CROX) has a profitability rating of 9 / 10.


What are the PE and PB ratios of CROCS INC (CROX) stock?

The Price/Earnings (PE) ratio for CROCS INC (CROX) is 7.15 and the Price/Book (PB) ratio is 3.45.


Can you provide the financial health for CROX stock?

The financial health rating of CROCS INC (CROX) is 7 / 10.